Anebulo Pharmaceuticals Quote - ANEB

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.57

Bid

1.47

Offer

1.58

Volume

417

1.57 Day's Range 1.57

0.8001 52 Week Range 3.30

Market Cap

40.715M

Previous Close

1.60

Open

1.57

Last Trade

1.578

Last Trade Time

01:48:34

Financial Volume

VWAP

Average Volume (3m)

31,956

Shares Outstanding

25,933,217

Dividend Yield

PE Ratio

-5.06

Earnings Per Share (EPS)

-0.32

Revenue

Net Profit

-8.2M

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of admini... Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.anebulo.com

Headquarters

Dover, Delaware, USA

Founded

Anebulo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ANEB. The last closing price for Anebulo Pharmaceuticals was US$1.60. Over the last year, Anebulo Pharmaceuticals shares have traded in a share price range of US$ 0.8001 to US$ 3.30.

Anebulo Pharmaceuticals currently has 25,933,217 shares in issue. The market capitalisation of Anebulo Pharmaceuticals is US$41.49 million. Anebulo Pharmaceuticals has a price to earnings ratio (PE ratio) of -5.06.

Form 8-K - Current report

Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the “Company”...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.05	-3.08641975309	1.62	1.7486	1.42	19823	1.59779746	CS
4	-0.115	-6.82492581602	1.685	1.7486	1.39	14277	1.57956871	CS
12	-0.06	-3.68098159509	1.63	1.8	0.8001	31956	1.411913	CS
26	-0.38	-19.4871794872	1.95	3.08	0.8001	18319	1.57858433	CS
52	-1.02	-39.3822393822	2.59	3.3	0.8001	12196	1.83698782	CS
156	-6.02	-79.3148880105	7.59	7.88	0.8001	10501	2.75021844	CS
260	-5.81	-78.7262872629	7.38	9.33	0.8001	11229	3.87702683	CS

ANEB - Frequently Asked Questions (FAQ)

What is the current Anebulo Pharmaceuticals share price?

The current share price of Anebulo Pharmaceuticals is US$ 1.57

How many Anebulo Pharmaceuticals shares are in issue?

Anebulo Pharmaceuticals has 25,933,217 shares in issue

What is the market cap of Anebulo Pharmaceuticals?

The market capitalisation of Anebulo Pharmaceuticals is USD 41.49M

What is the 1 year trading range for Anebulo Pharmaceuticals share price?

Anebulo Pharmaceuticals has traded in the range of US$ 0.8001 to US$ 3.30 during the past year

What is the PE ratio of Anebulo Pharmaceuticals?

The price to earnings ratio of Anebulo Pharmaceuticals is -5.06

What is the reporting currency for Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals reports financial results in USD

What is the latest annual profit for Anebulo Pharmaceuticals?

The latest annual profit of Anebulo Pharmaceuticals is USD -8.2M

What is the registered address of Anebulo Pharmaceuticals?

The registered address for Anebulo Pharmaceuticals is 838 WALKER ROAD, SUITE 21-2, KENT, DOVER, DELAWARE, 19904

What is the Anebulo Pharmaceuticals website address?

The website address for Anebulo Pharmaceuticals is www.anebulo.com

Which industry sector does Anebulo Pharmaceuticals operate in?

Anebulo Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
VLCNVolcon Inc	US$ 9.22 (176.05%)	24.72M
CAPTCaptiVision Inc	US$ 0.79 (79.95%)	16.3M
QNTMQuantum Biopharma Ltd	US$ 5.2536 (65.21%)	36.16M
GCTKGlucoTrack Inc	US$ 1.77 (55.26%)	24.79M
PTIRGraniteShares 2X Long PLTR Daily ETF	US$ 237.81 (53.11%)	946.86k
OMGAOmega Therapeutics Inc	US$ 0.26 (-45.73%)	1.49M
VIRXViracta Therapeutics Inc	US$ 0.0525 (-32.52%)	2.62M
UPCUniverse Pharmaceuticals Inc	US$ 0.2839 (-31.98%)	827.84k
PLTDDirexion Daily PLTR Bear 1X Shares	US$ 15.0176 (-26.67%)	3.65M
HCWBHCW Biologics Inc	US$ 0.4828 (-24.08%)	5.75M
PLTRPalantir Technologies Inc	US$ 106.2448 (26.87%)	69.57M
NVDANVIDIA Corporation	US$ 120.1922 (3.03%)	56.07M
EVAXEvaxion Biotech AS	US$ 3.498 (45.75%)	52.45M
IVVDInvivyd Inc	US$ 1.1401 (7.56%)	47.12M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.1589 (-18.47%)	47.06M